Literature DB >> 2887547

Structure of Bordetella pertussis peptidoglycan.

W J Folkening, W Nogami, S A Martin, R S Rosenthal.   

Abstract

Bordetella pertussis Tohama phases I and III were grown to the late-exponential phase in liquid medium containing [3H]diaminopimelic acid and treated by a hot (96 degrees C) sodium dodecyl sulfate extraction procedure. Washed sodium dodecyl sulfate-insoluble residue from phases I and III consisted of complexes containing protein (ca. 40%) and peptidoglycan (60%). Subsequent treatment with proteinase K yielded purified peptidoglycan which contained N-acetylglucosamine, N-acetylmuramic acid, alanine, glutamic acid, and diaminopimelic acid in molar ratios of 1:1:2:1:1 and less than 2% protein. Radiochemical analyses indicated that 3H added in diaminopimelic acid was present in peptidoglycan-protein complexes and purified peptidoglycan as diaminopimelic acid exclusively and that pertussis peptidoglycan was not O acetylated, consistent with it being degraded completely by hen egg white lysozyme. Muramidase-derived disaccharide peptide monomers and peptide-cross-linked dimers and higher oligomers were isolated by molecular-sieve chromatography; from the distribution of these peptidoglycan fragments, the extent of peptide cross-linking of both phase I and III peptidoglycan was calculated to be ca. 48%. Unambiguous determination of the structure of muramidase-derived peptidoglycan fragments by fast atom bombardment-mass spectrometry and tandem mass spectrometry indicated that the pertussis peptidoglycan monomer fraction was surprisingly homogeneous, consisting of greater than 95% N-acetylglucosaminyl-N-acetylmuramyl-alanyl-glutamyl-diaminopimelyl++ +-alanine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887547      PMCID: PMC213733          DOI: 10.1128/jb.169.9.4223-4227.1987

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  24 in total

Review 1.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

2.  Adjuvant activity of monomeric bacterial cell wall peptidoglycans.

Authors:  A Adam; R Ciorbaru; F Ellouz; J F Petit; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-02-04       Impact factor: 3.575

3.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

4.  Murein biosynthesis and O-acetylation of N-acetylmuramic acid during the cell-division cycle of Proteus mirabilis.

Authors:  J Gmeiner; H P Kroll
Journal:  Eur J Biochem       Date:  1981-06

5.  Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani; T Koga
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

6.  Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities.

Authors:  R S Rosenthal
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

7.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

8.  Macrophage activation by bacterial cell walls and related synthetic compounds.

Authors:  H Takada; M Tsujimoto; K Kato; S Kotani; S Kusumoto; M Inage; T Shiba; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments.

Authors:  R K Sinha; R S Rosenthal
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Extent of peptide cross-linking in the peptidoglycan of Neisseria gonorrhoeae.

Authors:  R S Rosenthal; R M Wright; R K Sinha
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  8 in total

1.  Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis.

Authors:  B T Cookson; H L Cho; L A Herwaldt; W E Goldman
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

2.  Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates.

Authors:  R Striker; M E Kline; R A Haak; R F Rest; R S Rosenthal
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  D-alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing.

Authors:  Neetu Kumra Taneja; Tridib Ganguly; Lauren O Bakaletz; Kimberly J Nelson; Purnima Dubey; Leslie B Poole; Rajendar Deora
Journal:  J Bacteriol       Date:  2013-09-06       Impact factor: 3.490

4.  The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall.

Authors:  K Costa; G Bacher; G Allmaier; M G Dominguez-Bello; L Engstrand; P Falk; M A de Pedro; F García-del Portillo
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

5.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology.

Authors:  K E Luker; J L Collier; E W Kolodziej; G R Marshall; W E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin.

Authors:  R S Rosenthal; W Nogami; B T Cookson; W E Goldman; W J Folkening
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Fundamental differences in physiology of Bordetella pertussis dependent on the two-component system Bvg revealed by gene essentiality studies.

Authors:  Thomas Belcher; Iain MacArthur; Jerry D King; Gemma C Langridge; Matthew Mayho; Julian Parkhill; Andrew Preston
Journal:  Microb Genom       Date:  2020-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.